all report title image

INTERVENTIONAL PAIN MANAGEMENT MARKET ANALYSIS

Interventional Pain Management Market, by Technique (Pain Management Injection (Epidural Steroid Injections, Facet Joint Injections, Medial Branch Blocks, Nerve Blocks, Sacroiliac Injections, Trigger Point Injections, and Others), Radiofrequency Ablation, Spinal Cord Stimulation, and Others), by Application (Back and Neck Pain, Diabetic Neuropathy, Cancer Pain, Foot & Ankle Pain, Joint Pain, Muscle Pain and Spasm, Post-Injury Pain, Shingles Pain, and Others), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Nov 2024
  • Code : CMI2273
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Interventional pain management is a technique of pain management with special procedures such as spinal cord stimulation and pain management injections. Interventional pain management techniques are provided by trained anesthesiologists at pain management clinics or centers. These techniques are widely used in the treatment of various types of pain, which includes back and neck pain, diabetic neuropathy, cancer pain, foot and ankle pain, and joint pain.

Interventional Pain Management Market: Drivers

Rising prevalence of chronic pain is expected to increase the demand for interventional pain management techniques for its treatment, thereby fueling interventional pain management market growth in the near future. For instance, according to a study published by the National Centre for Biotechnology Information (NCBI) in 2015, around 19.6% of the individuals aged between 20 to 60 years were suffering from low back pain worldwide.

According to a study published by the Centers for Disease Control and Prevention (CDC) in 2012, around 20.3% of the population in the U.S. suffer from lower back pain. As per the report of the American Academy of Pain Medicine (AAPM) 2012, over 100 million people suffer from chronic pain, 25.8 million from diabetes, 16.3 million from coronary heart disease, and 11.9 million from cancer in the U.S. every year, which is expected to further increase in the near future. Moreover, in 2015, the National Institutes of Health (NIH) estimated that one in 10 people in the U.S. suffer from chronic pain. According to a study published in the British Medical Journal in 2016, around one-third to half of the population in the U.K. suffers from chronic pain.

Increasing establishment of new national interventional pain management platform is expected to support growth of the global interventional pain management market over the forecast period. For instance, in February 2018, NexPhase Capital, LP acquired Gulf Coast Pain Institute, through which the company launched a new national interventional pain management platform named Clearway Pain Solutions Institute, which will provide interventional pain management therapies to patients suffering from chronic pain.

The chances of chronic pain in geriatric population is very high. Therefore, increasing geriatric population is expected to increase demand for interventional pain management and fuel global interventional pain management market growth over the forecast period. For instance, according to the data published by the United Nations Population Fund, people aged 60 years and above accounted for 12.3% of the global population in 2015, which is expected to increase to 22% by 2050, accounting for 2 billion people.

Interventional Pain Management Market: Regional Analysis

North America interventional pain management market is expected to grow drastically, owing to increasing promotional activities by interventional pain management providers to bring awareness about interventional pain management techniques among the population. For instance, in 2016, the Center for Interventional Pain and Spine launched its new website to bring awareness about the interventional pain management techniques among the population.

Increasing prevalence of chronic pain among population is expected to fuel interventional pain management market growth in Europe in the near future. For instance, according to the data published by World Health Organization (WHO) in 2015, around 20% of the adult population in Europe was suffering from chronic pain.

Increasing geriatric population in Asia Pacific region is expected to increase the demand for interventional pain management, which in turn is expected to drive interventional pain management market growth in the region. For instance, according to the data published by the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP) in 2016, Asia Pacific region constitutes around 60% of the world’s geriatric population. It is estimated that in 2016, around 547 million people were aged above 60 years in Asia Pacific region and this number is expected to double and reach around 1.3 billion by 2050.

Interventional Pain Management Market: Key Players

Key players operating in the global interventional pain management market include Ipsen group, Allergan Plc., Medytox Inc., Merz GmbH, Medtronic Plc., Boston Scientific Corporation, and St. Jude Medical, Inc.

Interventional Pain Management Market: Taxonomy

The global interventional pain management market is segmented on the basis of technique, application, and region.

By Technique-

  • Pain Management Injection
    • Epidural Steroid Injections
    • Facet Joint Injections
    • Medial Branch Blocks
    • Nerve Blocks
    • Sacroiliac Injections
    • Trigger Point Injections
    • Others
  • Radiofrequency Ablation
  • Spinal Cord Stimulation
  • Others

By Application-

  • Back and Neck Pain
  • Diabetic Neuropathy
  • Cancer Pain
  • Foot and Ankle Pain
  • Joint Pain
  • Muscle Pain and Spasm
  • Post-Injury Pain
  • Shingles Pain
  • Others

By Region-

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Share

About Author

Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.

Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.

Missing comfort of reading report in your local language? Find your preferred language :

Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Select a License Type





Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.